MYRIAD GENETICS INC — Director's Dealing 2022

Mar 1, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2022-02-28

Reporting Person: Hart Jayne B. (Chief People Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-02-28	Common Stock	M	7000	$23.98	Acquired	172878	Direct
2022-02-28	Common Stock	S	7000	$25.0	Disposed	165878	Direct
2022-02-28	Common Stock	M	3500	$23.98	Acquired	169378	Direct
2022-02-28	Common Stock	S	3500	$25.0	Disposed	165878	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-02-28	Incentive Stock Option (right to buy)	$23.98	M	3500	Disposed	2022-03-07	Common Stock (3500)	Direct
2022-02-28	Non-Qualified Stock Option (right to buy)	$23.98	M	7000	Disposed	2022-03-07	Common Stock (7000)	Direct

Footnotes

F1: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.

F2: Represents shares of common stock received upon exercise of a stock option award.

F3: The shares subject to this option are fully vested and exercisable.